Heidelberg, Germany

Andreas Baumann

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Andreas Baumann in Vaccine Development

Introduction

Andreas Baumann is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of immunology, particularly in the development of vaccination platforms. His work focuses on creating effective solutions for various medical conditions through innovative approaches.

Latest Patents

Andreas Baumann holds a patent for a "VSG-based vaccination and antibody generation platform for the treatment of diseases." This invention utilizes a platform that displays small molecular immunogenic compounds on the coat of variant surface glycoproteins (VSG) found on trypanosomes. The result is a highly effective immune response, making it suitable for use as a vaccine or for antibody production. The disclosed antigenic particles can be used to produce antibodies or directly serve as vaccines for treating various medical conditions. Notably, this invention is particularly relevant for developing VSG-based vaccines aimed at dependency-causing substances, addressing addiction, and preventing adverse events during drug abuse. Additionally, the platform has applications in treating or preventing cancer, infectious diseases, and neurodegenerative disorders.

Career Highlights

Andreas Baumann is affiliated with the Deutsches Krebsforschungszentrum, a prominent cancer research center in Germany. His work there emphasizes the importance of innovative vaccine development and antibody generation. His research has the potential to impact various fields, including addiction treatment and cancer therapy.

Collaborations

Andreas collaborates with esteemed colleagues, including Fotini Nina Papavasiliou and Hamidreza Hashemi. Their combined expertise enhances the research and development of novel immunological solutions.

Conclusion

Andreas Baumann's innovative work in vaccine development showcases the potential of VSG-based platforms in addressing critical health issues. His contributions to immunology are paving the way for advancements in treatment and prevention strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…